Sulindac treatment in hereditary non-polyposis colorectal cancer
- 1 May 2007
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 43 (8) , 1251-1256
- https://doi.org/10.1016/j.ejca.2007.03.001
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Hereditary Colorectal CancerNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort studyGastroenterology, 2002
- Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesJNCI Journal of the National Cancer Institute, 2002
- Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferationGut, 2001
- Chemoprevention of Colorectal CancerNew England Journal of Medicine, 2000
- Lessons from Hereditary Colorectal CancerCell, 1996
- Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathwayBiochemical Pharmacology, 1996
- Aspirin and the Risk of Colorectal Cancer in WomenNew England Journal of Medicine, 1995
- Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous PolyposisNew England Journal of Medicine, 1993